Direkt zum Inhalt
Merck

Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.

Journal of the National Cancer Institute (2013-12-10)
Hiromasa Yamamoto, Koichiro Higasa, Masakiyo Sakaguchi, Kazuhiko Shien, Junichi Soh, Koichi Ichimura, Masashi Furukawa, Shinsuke Hashida, Kazunori Tsukuda, Nagio Takigawa, Keitaro Matsuo, Katsuyuki Kiura, Shinichiro Miyoshi, Fumihiko Matsuda, Shinichi Toyooka
ZUSAMMENFASSUNG

We encountered a family of Japanese descent in which multiple members developed lung cancer. Using whole-exome sequencing, we identified a novel germline mutation in the transmembrane domain of the human epidermal growth factor receptor 2 (HER2) gene (G660D). A novel somatic mutation (V659E) was also detected in the transmembrane domain of HER2 in one of 253 sporadic lung adenocarcinomas. Because the transmembrane domain of HER2 is considered to be responsible for the dimerization and subsequent activation of the HER family and downstream signaling pathways, we performed functional analyses of these HER2 mutants. Mutant HER2 G660D and V659E proteins were more stable than wild-type protein. Both the G660D and V659E mutants activated Akt. In addition, they activated p38, which is thought to promote cell proliferation in lung adenocarcinoma. Our findings strongly suggest that mutations in the transmembrane domain of HER2 may be oncogenic, causing hereditary and sporadic lung adenocarcinomas.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Glycin, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Glycin, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
L-Glutaminsäure, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Asparaginsäure, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Glycin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
Sigma-Aldrich
L-Glutaminsäure, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
SAFC
Glycin
Sigma-Aldrich
Glycin -hydrochlorid, ≥99% (HPLC)
Sigma-Aldrich
L-Valin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Asparaginsäure, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Glutaminsäure, BioUltra, ≥99.5% (NT)
SAFC
L-Valin
Sigma-Aldrich
L-Asparaginsäure, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
Glycin, BioXtra, ≥99% (titration)
Sigma-Aldrich
D-Glutaminsäure, ≥99% (TLC)
Sigma-Aldrich
L-Asparaginsäure Kaliumsalz, ≥98% (HPLC)
Sigma-Aldrich
L-Valin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-Asparaginsäure, BioUltra, ≥99.5% (T)
Sigma-Aldrich
DL-Asparaginsäure, ≥99% (TLC)
Sigma-Aldrich
Glycin 1 M -Lösung
SAFC
L-Asparaginsäure
Sigma-Aldrich
Glycin, 99%, FCC
Sigma-Aldrich
L-Glutaminsäure, FCC
Sigma-Aldrich
L-Valin, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Glycin, ACS reagent, ≥98.5%
Sigma-Aldrich
Glycin, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
Supelco
Glycin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutaminsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Valin, Pharmaceutical Secondary Standard; Certified Reference Material